Skip to main content
TipRanks
Go Ultimate75% OFF

MeVis Medical Solutions (0HI7) Ratios

0 Followers

MeVis Medical Solutions Ratios

GB:0HI7's free cash flow for Q2 2026 was €0.00. For the 2026 fiscal year, GB:0HI7's free cash flow was increased by €0.00 and operating cash flow was €0.00. See a summary of the company’s cash flow.

Financial ratios
RatiosSep 25Sep 24Sep 23Sep 22Sep 21
Liquidity Ratios
Current Ratio1.581.501.661.501.62
Quick Ratio1.581.501.661.491.61
Cash Ratio1.141.031.130.961.14
Solvency Ratio0.410.540.490.590.48
Operating Cash Flow Ratio0.680.490.850.501.36
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value€ 992.23K€ 890.18K€ 1.14M€ 1.13M€ 1.17M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.000.000.00
Debt-to-Capital Ratio0.000.000.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.451.491.571.751.54
Debt Service Coverage Ratio5741.98239.22118.120.00432.68
Interest Coverage Ratio4058.20204.00150.470.00596.20
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.010.020.000.01
Net Debt to EBITDA-1.90-1.35-1.50-1.17-1.60
Profitability Margins
Gross Profit Margin97.70%97.11%40.38%96.02%97.31%
EBIT Margin20.42%27.73%29.27%42.00%28.63%
EBITDA Margin21.33%28.40%29.83%42.48%29.40%
Operating Profit Margin14.58%23.58%37.16%33.53%39.79%
Pretax Profit Margin20.41%27.62%29.03%41.98%28.56%
Net Profit Margin19.71%26.87%28.37%41.52%28.04%
Continuous Operations Profit Margin19.71%26.87%28.37%41.52%28.04%
Net Income Per EBT96.56%97.30%97.73%98.89%98.16%
EBT Per EBIT140.02%117.12%78.12%125.21%71.78%
Return on Assets (ROA)12.23%17.22%17.54%24.96%16.51%
Return on Equity (ROE)17.76%25.59%27.60%43.69%25.50%
Return on Capital Employed (ROCE)11.61%19.89%30.39%29.22%30.96%
Return on Invested Capital (ROIC)11.16%19.44%29.70%28.90%30.39%
Return on Tangible Assets12.23%17.22%17.54%24.96%16.51%
Earnings Yield7.01%10.90%9.52%12.51%7.66%
Efficiency Ratios
Receivables Turnover7.056.146.543.855.59
Payables Turnover2.575.73134.733.881.82
Inventory Turnover0.000.000.005.594.36
Fixed Asset Turnover52.0253.84118.73115.80133.13
Asset Turnover0.620.640.620.600.59
Working Capital Turnover Ratio4.924.403.714.164.18
Cash Conversion Cycle-90.44-4.2753.1165.86-51.34
Days of Sales Outstanding51.7859.4655.8194.7665.26
Days of Inventory Outstanding0.000.000.0065.2483.72
Days of Payables Outstanding142.2263.742.7194.15200.32
Operating Cycle51.7859.4655.81160.00148.98
Cash Flow Ratios
Operating Cash Flow Per Share2.131.733.222.675.02
Free Cash Flow Per Share2.051.563.172.604.99
Dividend Paid and CapEx Coverage Ratio0.830.600.741.041.59
Capital Expenditure Coverage Ratio27.6210.4273.4436.49179.53
Operating Cash Flow Coverage Ratio0.000.000.000.000.00
Operating Cash Flow to Sales Ratio0.240.190.340.260.56
Free Cash Flow Yield8.28%6.80%11.17%7.59%15.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio14.259.1810.517.9913.05
Price-to-Sales (P/S) Ratio2.812.472.983.323.66
Price-to-Book (P/B) Ratio2.532.352.903.493.33
Price-to-Free Cash Flow (P/FCF) Ratio12.0714.728.9513.186.53
Price-to-Operating Cash Flow Ratio11.6413.308.8312.816.50
Price-to-Earnings Growth (PEG) Ratio-0.46-1.30-0.280.11-0.65
Enterprise Value Multiple11.277.338.506.6410.85
Enterprise Value38.61M35.33M43.94M52.92M51.71M
EV to EBITDA11.277.338.506.6410.85
EV to Sales2.402.082.532.823.19
EV to Free Cash Flow10.3312.427.6111.205.69
EV to Operating Cash Flow9.9511.237.5110.905.66
Tangible Book Value Per Share9.799.799.799.799.79
Shareholders’ Equity Per Share9.799.799.799.799.79
Tax and Other Ratios
Effective Tax Rate0.030.030.020.010.02
Revenue Per Share8.829.339.5310.318.91
Net Income Per Share1.742.512.704.282.50
Tax Burden0.970.970.980.990.98
Interest Burden1.001.000.991.001.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.030.030.030.020.05
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality1.230.691.190.622.01

Currency in EUR